Back to Search Start Over

Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities - ResearchAndMarkets.com

Source :
Business Wire. May 14, 2020
Publication Year :
2020

Abstract

DUBLIN -- The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.623800899